Diamines & Chemicals (DIAMINESQ)₹233.93+1.66%Specialty Chemicals
In the Sep 2026 quarter (consolidated), Diamines & Chemicals reported sales of ₹9.89 Cr, up 6.2% from Sep 2025, and net profit of −₹2.19 Cr. For the year to Mar 2026, sales were ₹38.47 Cr and net profit −₹12.79 Cr.
Company filings, consolidated accounts; latest reported quarter Sep 2026
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 23.06 | 29.44 | 16.87 | 19.21 | 17.55 | 17.96 | 12.26 | 9.31 | 7.65 | 9.30 | 14.40 | 9.89 |
| Expenses | 18.33 | 26.04 | 18.24 | 15.60 | 16.03 | 16.27 | 16.22 | 13.21 | 10.52 | 12.43 | 14.02 | 11.64 |
| Operating Profit | 4.73 | 3.37 | −1.35 | 3.62 | 1.53 | 1.70 | −3.94 | −3.88 | −2.85 | −3.12 | 0.39 | −1.74 |
| OPM % | 20.5% | 11.5% | −8.1% | 18.8% | 8.7% | 9.4% | −32.2% | −41.8% | −37.4% | −33.5% | 2.7% | −17.7% |
| Other Income | 0.59 | 0.67 | 0.67 | 0.82 | 0.78 | 0.94 | 1.90 | 0.62 | 0.54 | 0.93 | 0.52 | 0.60 |
| Interest | 0.12 | 0.00 | 0.02 | 0.05 | 0.16 | 0.08 | 0.00 | 0.06 | 0.12 | 0.09 | 0.01 | 0.00 |
| Depreciation | 0.93 | 0.72 | 0.85 | 0.87 | 0.87 | 0.88 | 0.88 | 0.95 | 0.97 | 0.95 | 0.91 | 0.95 |
| Profit before tax | 4.22 | 3.31 | −1.58 | 3.47 | 1.23 | 1.65 | −2.95 | −4.29 | −3.43 | −3.24 | −0.04 | −2.12 |
| Tax % | 30.5% | 33.4% | 6.9% | 27.3% | 34.6% | 20.4% | −7.5% | −5.6% | −3.2% | −25.9% | 0.0% | 0.0% |
| Net Profit | 2.81 | 2.26 | −1.74 | 2.45 | 0.76 | 1.27 | −2.80 | −4.16 | −3.39 | −2.43 | −0.11 | −2.19 |
| EPS (Rs) | 2.87 | 2.31 | −1.80 | 2.52 | 0.78 | 1.30 | −2.88 | −4.25 | −3.49 | −2.42 | −0.11 | −2.20 |
| Mar 2015 | Mar 2016 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 39.16 | 35.67 | 62.97 | 66.04 | 111 | 104 | 71.54 | 38.47 | 41.24 |
| Expenses | 34.20 | 31.16 | 37.24 | 43.99 | 54.78 | 81.42 | 66.07 | 52.22 | 48.61 |
| Operating Profit | 4.92 | 4.45 | 25.59 | 22.05 | 55.56 | 22.65 | 5.47 | −13.68 | −7.32 |
| OPM % | 12.6% | 12.6% | 40.8% | 33.5% | 50.4% | 21.8% | 7.6% | −35.6% | −17.8% |
| Other Income | 0.19 | 0.37 | 2.06 | 1.80 | 2.66 | 2.57 | 3.16 | 3.81 | 2.59 |
| Interest | 3.40 | 2.74 | 0.07 | 0.08 | 0.13 | 0.19 | 0.33 | 0.30 | 0.22 |
| Depreciation | 2.02 | 1.98 | 1.78 | 1.66 | 1.77 | 2.84 | 3.50 | 3.77 | 3.78 |
| Profit before tax | −0.32 | 0.07 | 25.74 | 22.03 | 56.16 | 22.13 | 4.76 | −13.92 | −8.83 |
| Tax % | 378.7% | −212.5% | 18.6% | 24.3% | 25.6% | 28.4% | 38.0% | −10.2% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | −1.60 | 0.24 | 20.98 | 16.72 | 41.91 | 15.48 | 2.74 | −12.79 | −8.12 |
| EPS (Rs) | −1.64 | 0.27 | 21.52 | 17.13 | 42.94 | 15.85 | 2.80 | −12.75 | −8.22 |
| Dividend payout % | 0.0% | 0.0% | 23.3% | 17.6% | 7.0% | 15.8% | 35.9% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 9.76 | 9.77 | 9.75 | 9.76 | 9.75 | 9.76 | 9.76 | 10.02 |
| Reserves | 22.78 | 23.02 | 75.16 | 90.44 | 125 | 138 | 152 | 147 |
| Borrowings | 20.13 | 15.57 | 0.31 | 0.00 | 0.00 | 0.00 | 0.04 | 8.19 |
| Other Liabilities | 10.01 | 8.64 | 9.45 | 10.31 | 16.48 | 14.49 | 16.73 | 8.71 |
| Total Liabilities | 62.68 | 57.00 | 94.67 | 111 | 151 | 163 | 178 | 174 |
| Fixed Assets | 29.38 | 27.40 | 22.52 | 37.66 | 40.15 | 65.53 | 63.94 | 65.24 |
| CWIP | 1.16 | 1.19 | 0.14 | 1.87 | 21.33 | 0.82 | 2.25 | 19.34 |
| Investments | 0.09 | 0.07 | 5.93 | 12.65 | 13.29 | 15.73 | 16.06 | 10.19 |
| Other Assets | 32.05 | 28.34 | 66.08 | 58.33 | 76.17 | 80.62 | 95.89 | 79.54 |
| Inventories | 12.07 | 9.16 | 12.52 | 2.29 | 16.81 | 17.34 | 31.61 | 28.29 |
| Trade receivables | 7.81 | 7.40 | 9.46 | 10.04 | 22.93 | 16.73 | 13.87 | 5.48 |
| Cash & equivalents | 0.49 | 0.60 | 32.72 | 40.63 | 27.08 | 38.04 | 41.52 | 32.84 |
| Total Assets | 62.68 | 57.00 | 94.67 | 111 | 151 | 163 | 178 | 174 |
| Mar 2015 | Mar 2016 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 2.48 | 7.11 | 15.35 | 27.23 | 16.25 | 21.88 | −5.01 | −10.83 |
| Cash from investing activity | 0.52 | 0.09 | −14.96 | −21.54 | −8.67 | −18.87 | 14.68 | −28.98 |
| Cash from financing activity | −3.05 | −7.28 | −3.68 | −5.27 | −6.00 | −3.12 | 9.74 | 18.00 |
| Net cash flow | −0.05 | −0.08 | −3.24 | 0.49 | 1.60 | −0.06 | 19.37 | −21.73 |
| Capex | 0.11 | 0.05 | 11.34 | 15.00 | 23.33 | 8.63 | 4.02 | 21.40 |
| Free cash flow | 2.45 | 7.07 | 4.05 | 14.53 | −7.00 | 13.39 | −8.95 | −32.07 |
| CFO / OP % | 53.9% | 160.9% | 84.9% | 152.0% | 55.9% | 124.9% | −75.1% | 72.9% |
| Mar 2015 | Mar 2016 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Debtor days | 73 | 76 | 55 | 55 | 76 | 59 | 71 | 52 |
| Inventory days | 184 | 155 | 284 | 43 | 234 | 135 | 336 | 503 |
| Days payable | 52 | 34 | 65 | 45 | 105 | 40 | 93 | 47 |
| Cash conversion cycle | 204 | 195 | 272 | 53 | 203 | 153 | 312 | 507 |
| Working capital days | 31 | 25 | 102 | 39 | 95 | 93 | 184 | 243 |
| ROCE % | 5.8% | 5.6% | — | 24.0% | 48.3% | 15.9% | 3.4% | −8.2% |
For the Sep 2026 quarter, Diamines & Chemicals reported sales of ₹9.89 Cr, up 6.2% year on year and net profit of −₹2.19 Cr. The operating margin was −17.7%.
Diamines & Chemicals' sales for the year to Mar 2026 were ₹38.47 Cr; over the last twelve months they were ₹41.24 Cr.
Net profit for the year to Mar 2026 was −₹12.79 Cr, and −₹8.12 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−8.22.
Diamines & Chemicals reported borrowings of ₹8.19 Cr at Mar 2026, against cash and equivalents of ₹32.84 Cr.
Cash from operations was −₹10.83 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹32.07 Cr.